Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 14 Breast Neoplasms 13 Lung Neoplasms 10 Uterine Cervical Neoplasms 9 Neoplasms 8 Colonic Neoplasms 5 Hematopoietic and Lymphatic System Neoplasm 4 Prostatic Neoplasms 3 Papillomavirus Infections 3 Liver Neoplasms 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Patient Compliance 2 Neoplasm Metastasis 2 Hematologic Neoplasms 2 Colorectal Cancer Screening 2 Carcinoma, Intraductal, Noninfiltrating 2 Tobacco Use 1 Smoking 1 Pyloric Stenosis, Hypertrophic 1 Psychological Well-Being 1 Overweight 1 Obesity 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma 1 Liver Diseases 1 Hypertension 1 Hepatitis C 1

Interventions

Cisplatin 257 Radiotherapy 193 Cetuximab 150 pembrolizumab 123 Docetaxel 96 Fluorouracil 92 Carboplatin 80 Paclitaxel 78 Radiotherapy, Intensity-Modulated 72 Surveys and Questionnaires 46 Nivolumab 42 Drug Therapy 34 Radiation 33 Blood Specimen Collection 27 Erlotinib Hydrochloride 26 Gemcitabine 25 Immunohistochemistry 22 Gefitinib 22 Surgical Procedures, Operative 21 Cyclophosphamide 21 durvalumab 19 Standard of Care 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 19 Radiosurgery 17 Capecitabine 17 Chemotherapy, Adjuvant 16 Celecoxib 16 Biopsy 16 atezolizumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Patient Navigation × Clear all

NCT03821064 2021-02-01

NDURE

Medical University of South Carolina

Phase NA Completed

11 enrolled 28 charts

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡